HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes-Reference-Cited by-同舟云学术

HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes

Published:1997-12 Issue:2-3 Volume:93 Page:215-219
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Inaba T,Fischer N.E,Riddick D.S,Stewart D.J,Hidaka T

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference15 articles.

1. Protease inhibitors in patients with HIV disease;Barry;Clin. Pharmacokinet.,1997

2. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions;Bertz;Clin. Pharmacokinet.,1997

3. The clinical pharmacokinetics of rifabutin;Blaschke;Clin. Infect. Dis.,1996

4. Role of cytochrome P450 3A4 in human metabolism of MK-639 (indinavir), a potent human immunodeficiency virus protease inhibitor;Chiba;Drug Metab. Dispos.,1996

5. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes;Chiba;Biochem. Pharmacol.,1997

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions;Pharmacological Research;2020-11

2. Optimizing HIV prevention and care for transgender adults;AIDS;2019-03-01

3. Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model;Andrology;2014-06-12

4. Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma;JAIDS Journal of Acquired Immune Deficiency Syndromes;2012-04-15

5. Avoiding statin myopathy: understanding key drug interactions;Clinical Lipidology;2011-12-01